Connect with us

Hi, what are you looking for?

Investing

Trump’s First 100 Days: Health Policy

Michael F. Cannon

HHS Secretary Robert F. Kennedy, Jr. promises "gold standard" science

How did the Trump administration perform on health policy in its first 100 days? A flurry of activity is not the same as progress. 

President Trump has taken positive steps on health policy, such as withdrawing former President Biden’s unlawful plan to have Medicare cover weight-loss drugs. But he has been unforgivably AWOL on the dire need for fundamental reform of Medicare, Medicaid, CHIP, Obamacare, the VHA, and the FDA. And his administration has intemperately cast doubt on the efficacy of vaccines, the most beneficial medical interventions in human history. 

Many Trump actions that could potentially be positive, such as reducing the HHS workforce, may actually prove negative by paradoxically increasing government interference in health care markets. 

Many otherwise positive steps—including many spending and job cuts—appear to be ephemeral at best and, at worst, illegal. Even when the president or his advisors are trying to implement good policy, it would be better if they did nothing rather than violate the law to do it. 

Unfortunately, the president and his advisors are perpetuating a vicious and dangerous cycle of successive administrations violating the law to reward their friends, punish their enemies, and achieve ideological goals that lack democratic support.

Advertisement

    You May Also Like

    Investing

    Adam N. Michel As Congress debates how to extend the expiring 2017 Trump tax cuts, a new poll from the Cato Institute suggests the...

    Investing

    Jeffrey A. Singer Last week, President Donald Trump told a National Republican Congressional Committee audience that he intends to impose tariffs on pharmaceutical products...

    Investing

    David J. Bier Today Cato published my new briefing paper coauthored with Mike Howard and Jacob Vigdor on how immigration has affected housing wealth...

    Stocks

    In what can be called an indecisive week for the markets, the Nifty oscillated back and forth within a given range and ended the...